Curriculum Vitae.doc
-
Upload
terrybear11 -
Category
Documents
-
view
922 -
download
6
description
Transcript of Curriculum Vitae.doc
Curriculum VitaeJames Andrew Brown, M.D., F.A.C.S.
Revised October, 2005
Address:Medical College of Georgia1120 15th Street, BA-8408, Augusta, GA 30912-4050Phone: (706) 721-9977; Fax: 721-2548; Email:
HREF="mailto:[email protected]"
Birth:July 16, 1964, Sacramento, California
Current Position:Associate Professor, Medical College of Georgia Head, Urologic OncologyConsultant, Veterans Affairs Medical Center, Augusta, GA
Education:Fort Collins High School, Fort Collins, Colorado, 1979-82University of Wyoming, Laramie, Wyoming, 1982-83Colorado State University, Fort Collins, Colorado, B.S. Engineering
Science 1986Baylor College of Medicine, Houston, Texas, M.D., 1991
Surgical Training:Internship, General Surgery: Mayo Graduate School of Medicine,
1991-92Residency, Urology: Mayo Graduate School of Medicine, Rochester, MN,
1992-1997
Fellowship Training:Fellow, Minimally Invasive Urologic Oncology, Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, PA, January 2-April 12, 2002
Supervisor: Leonard G. Gomella, M.D.Focus: Hand-assisted laparoscopic renal surgery, transperitoneal laparoscopic prostatectomy & endoscopic tumor ablation
Fellow, Urologic Laparoscopy (Observer, Urologic Oncology), Indiana University
Indiana Cancer Pavilion, Indianapolis, IN, January 6 -April 4, 2003Supervisor: Chandru Sundaram, M.D.
Focus: Standard laparoscopic radical & donor nephrectomy, laparoscopic adrenalectomy, robotic pyeloplasty, open RPLND & continent urinary diversion
Fellow, Laparoscopic Urologic Oncology, Harvard University, Massachusetts General Hospital, Boston, MA, April 7 – July 3, 2003
Supervisor: Douglas M. Dahl, M.D.Focus: Extraperitoneal laparoscopic radical prostatectomy,
Standard laparoscopic renal surgery
Observer, Advanced Laparoscopic Urologic Oncology, Lahey Clinic, Burlington, MA,
April 7 – July 3, 2003Supervisor: Ingolf Tuerk, M.D.Focus: Advanced laparoscopic techniques: prostatectomy with Sural nerve graft, partial nephrectomy, partial & radical cystectomy, BPLND, RPLND &pyeloplasty
Fellow, Robotic-assisted laparoscopic urologic oncology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, April 18 –July 16, 2004
Supervisor: Mani Menon, M.D.Focus: daVinci robotic-assisted laparoscopic radical
prostatectomy
Board Certification:American Board of Urology (Certificate # 11918), 1999
Licensure:Georgia Composite State Board of Medical Examiners (050075), May
2001Drug Enforcement Agency (BB7275250), July 2004
Previous positions:Staff Urologist, David Grant USAF Medical Center, Travis AFB, CA,
1997-99Chief, Urology, David Grant USAF Medical Center, Travis AFB, CA,
1999-2001Assistant Professor, Medical College of Georgia, Augusta, GA, Jul
2001-Jun 2005Staff Urologist, Veterans Affairs Medical Center, Augusta, GA, Jul 2001-
Nov 2002
Administrative responsibilities:
2
Coordinator, Urology Grand Rounds, Medical College of Georgia, 2001-Present
Preceptor, Physical Diagnosis Course, Medical College of Georgia, 2001-Present
Honors/Awards:Youth Merit Award, Fort Collins Rotary Club, 1982Intrafraternity Council Scholastic Achievement Award, University of
Wyoming, 1983Honors at Entrance, Dormitory Honors Floor, Colorado State University,
1983Golden Key National Honor Society, Colorado State University, 1985Phi Kappa Phi National Honor Society, Colorado State University, 1986Tau Beta Phi National Engineering Honor Society, Colorado State
University, 1986Graduated with High Distinction (top 4% Engineering Class), Colo. St.
Univ., 1986American Urological Association, 1995, Best Poster of SessionDonald C. Balfour Award Nominee (outstanding resident research),
Mayo Clinic, 1996Kelalis Resident Essay Competition, Minnesota Urological Society - First
Place, 1997USAF Commendation Medal (Meritorious Service on Active Duty 7/97 –
7/01), 2001Georgia Cancer Coalition Distinguished Cancer Clinician Scientist
Award, 2001Georgia Cancer Coalition Distinguished Cancer Scholar, 2004President-elect, Georgia Urological Association, September 2004-
September 2005 Georgia Urology Resident Research Competition 2nd prize, 2005 (faculty mentor)
President, Georgia Urological Association, September 10, 2005 - present
Professional Societies and Offices Held:American College of SurgeonsGeorgia Chapter of American College of SurgeonsAmerican Urological AssociationAmerican Urological Association - Southeastern SectionGeorgia Urological Association President-elect, October 2004-October 2005Society of Urologic OncologySociety of Laparoendoscopic SurgeonsSociety for Basic Urologic ResearchSociety of Government Service Urologists
Editorial Boards:
3
Ad Hoc Reviewer:Surgical Laparoscopy, 2001-presentJournal of Urology, 2005-presentUROLOGY, 2005-presentJournal of Endourology, 2005-present
Committees:Tumor Board, David Grant USAF Medical Center, 1997-2001Tissue and Transfusion Committee, David Grant USAF Medical Center,
1998-1999Ethics Committee, David Grant USAF Medical Center, 1999-2001Prostate Cancer Screening Program, David Grant USAF Medical Center,
1998-2001Cancer Committee, Medical College of Georgia, 2001-PresentLaparoscopy Training Center Development Committee, MCG,
2002-PresentRobotic Surgery Development Committee, MCG, 2002-PresentUrologic Physician Assistant Advisory Committee, MCG, 2002-PresentPPG Marketing and Managed Care Committee, MCG April 2005 -
Present
Current Funding: National Peer Review Grants:
Local Peer Review Grants:Title: GCC Clinician and Scientist AwardRole: Principal InvestigatorValue: $300,000Funding Period: 1/02 – 12/06
Industry – Sponsored Studies:Title: “A randomized double-blind, placebo-controlled, multicenter efficacy and safety study of Toremifene citrate for the prevention of bone fractures in men with prostate cancer on ADT”Role: Principal InvestigatorValue: $95,700 (contract)Funding period: 2004-2006
Prior Funding: National Peer-Reviewed Grants:
Local Peer-Reviewed Grants:Title: “Use of polymerase chain reaction for detection of p53 and von Hippel-Lindau gene mutations and their clinical efficacy in determining progression of renal cell carcinoma”
4
Role: Principal InvestigatorSource: Department of Defense (DOD), David Grant USAF Medical CenterFunding Period: 1998-2001
Title: “Patterns of Care, Outcomes and Prognostic Analysis Prostate Cancer Database” Role: Principal InvestigatorSource: DOD, David Grant USAF Medical Center Funding Period: 1998-2001.
Title: “Marketing Prostate Care Through a Women’s Wellness Center”Role: Co-InvestigatorSource: DOD, David Grant USAF Medical Center Funding Period: 1998-2001.
Title: “Laparoscopic Surgical Skills Laboratory for Military Urologists Using Pigs (Sus Scorfa)”Role: Principal InvestigatorSource: DOD, David Grant USAF Medical CenterFunding Period: 1998-2001.
Industry-Sponsored Studies:
Title: “The Efficacy, Onset of Effect and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (Alf-Acute)”Role: Sub-InvestigatorSource: Sanofi-SythalaboFunding period: 2001-2002.
Title: “A Double-Blind, Randomized, Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of Acute Urinary Retention in Patients with a First Episode of BPH”Role: Sub-Investigator Source: Sanofi-SythalaboFunding period: 2001-2002.
Title: “Preoperative and Postoperative Erectile Function in Radical Prostatectomy Patients”Role: Sub-InvestigatorSource: Medical College of GeorgiaFunding period: 2001-2002.
5
Title: “A Placebo-Controlled, Double-Blind, Randomized, Parallel Study of the Efficacy and Safety of Dapozetine Hcl in the Treatment of Rapid Ejaculation”Role: Sub-InvestigaotrSource: PPD DevelopmentFunding period: 2003.
Title: “An Open Label Study of the Long-Term Safety of Dapoxetine Hcl in the Treatment of Rapid Ejaculation”Role: Sub-InvestigatorSource: PPD DevelopmentFunding period: 2003.
Title: “A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating Zoledronate Plus Standard Therapy vs Placebo Plus Standard Therapy in Patients with Recurrent Carcinoma of the Prostate Who Are Asymptomatic with Castrate Level Testosterone”Role: Sub-InvestigatorSource: NorvartisFunding period: 2002-2003.
Title: “A randomized, Double-Blind, Placebo-Controlled, Parallel Group Study for the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy Detectable Prostate Cancer”Role: Principal InvestigatorSource: GlaxoSmithKlineFunding period: 2003
Title: “A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Rofecoxib in Decreasing the Risk of Prostate Cancer (ViP Study)”Role: Principal InvestigatorSource: MerckFunding period: 2003 – 2004
Invited Lectures:1. Prostate cancer update: 2002, Hand-assisted laparoscopic surgery and
its applications to urologic laparoscopy and Laparoscopic radical prostatectomy: Fad or future? Rinker-Witherington Urologic Society, Augusta, GA, February 2002.
2. Laparoscopic radical prostatectomy. Us-Too Prostate Cancer Support Group, Augusta, GA, June 2002.
3. Minimally invasive surgical approach to urologic oncology. Dean’s Symposium, Medical College of Georgia, Augusta, GA, September 2002.
6
4. Testis cancer management: A 2003 update. Rinker-Witherington Urologic Society, Augusta, GA, February 2003.
5. Hand-assisted laparoscopic nephroureterectomy: A 2004 update. Rinker-Witherington Urological Society Annual Meeting, Augusta, GA, February 2004.
6. Prostate cancer: Rationale for screening. Rinker-Witherington Urological Society Annual Meeting, Augusta, GA, February 2004.
7. Update on prostate cancer: What to do with an elevated PSA? 39th Annual Primary Care and Family Practice Symposium, Augusta, GA, February 2004.
8. Robotic urological surgery: 2004 update. Georgia Urological Association and Urology Resident Research Expo, Lake Oconee, GA, March 2004.
9. Prostate cancer screening update. Shift meeting speaker at Thomson Plastics, Thomson, GA, March 2004.
10. Minimally Invasive Urologic Oncology: 2004 Update. Georgia Surgical Society annual meeting, Sea Island, GA, September 2004
11. Minimally Invasive Prostate Surgery: 2004 Update. Georgia Urological Association annual meeting, Sea Island, GA, September 2004
12. Minimally Invasive Renal Surgery: 2004 Update. Georgia Urological Association annual meeting, Sea Island, GA, September 2004
13. Short Term Trainee Perspective. Henry Ford Vattikuti Urology Institute 2004 International Robotic Urology Symposium, October 2004.
14. Prostate Cancer: The Basics. Medical College of Georgia Mini-Medical School lecture series, November 2004
15. Minimally Invasive Renal Surgery: 2005 Update. Macon Georgia Urology meeting. Jan 27, 2005
16. Minimally Invasive Prostate Surgery: 2005 Update. Visiting Professor at University of Florida. Gainesville, Florida. February 1-3, 2005.
17. Medical Treatment Options for the BPH Patient. Bistro 491, Augusta, GA, April 21, 2005.
18. Medical Treatment Options for the BPH Patient. Calvert’s, Augusta, GA, August 11, 2005.
19. Medical Treatment Options for the BPH Patient. Dublin, GA, August 12, 2005.
20. Prostate Cancer Awareness. Channel 6 noonday show. Augusta, GA, September 6, 2005
21. Minimally-invasive Renal Surgery: a 2005 Update. Medical College of Georgia General Surgery department Grand Rounds, Augusta, GA, September 12, 2005
22. Prostate Cancer Awareness. Channel 12 morning show. North Augusta, SC, September 14, 2005.
23. Prostate Cancer surgery. Medical College of Georgia Medical School student lecture. Augusta, GA, October 21, 2005.
7
Course Instruction:1. Update on prostate cancer: What to do with an elevated PSA? 39th
Annual Primary Care and Family Practice Symposium, Augusta, GA, February 2004.
2. Prostate Cancer. Medical College of Georgia medical student lecture. March 2004
3. Prostate Cancer: The Basics. Medical College of Georgia Mini-Medical School lecture series, November 2004
4. Prostate Cancer. Medical College of Georgia medical student lecture. March 22, 2005
Course Completion:1. American Heart Association Basic Life Support July 20032. American Heart Association Advanced Life Support Jan 20003. American College of Surgeons Advanced Trauma Life Support
Nov 19974. American College of Surgeons ATLS Instructor Course May 19995, Society of Critical Care Medicine Fundamentals of Critical Care Support Aug 2005
Community Activities:Community Leadership Council Member, American Cancer Society,
2002-presentUrologic Commentator, ABC and NBC Affiliates, Augusta, GA,
2002-presentSoutheast Georgia Cancer Alliance Inc., Speakers Bureau Member ,
2004Speaker, Us-Too Prostate Cancer Support Group, Augusta, GA, 2001 –
presentProstate Cancer Speaker, Thomson Plastics, Thomson, GA, 2004Choir member/Lector, Christ The King Lutheran church, Evans, GA,
2001 - presentAssistant basketball coach, 4th grade boys church league, Augusta, GA,
2004-2005Pinewood Derby coordinator, Cub Scout Pack 56, Martinez, GA, Feb-Mar
2005
Abstract Presentations (*presenter):1. Jenkins RB, Brown JA*, Alcaraz A, Takahashi S, Persons DL, Katzmann
JA, Lieber MM: Fluorescent in situ hybridization (FISH) for ploidy analysis in prostate adenocarcinoma. NIH Annual SPORE meeting – Mayo Feasibility Group, Rockville MD, July 1993.
8
2. Cher ML*, Carroll PR, Jensen RH, MacGrogan D, Bookstein R, Brown JA, Jenkins R: Comparative genomic hybridization and allelic imbalance of chromosome 8 in prostate cancer. Society for Basic Urologic Research meeting, Houston TX, November 1993.
3. Jenkins R, Brown JA*, Takahashi S, Alcaraz A: An Evaluation of the Clinical Utility of Fluorescent in situ Hybridization (FISH) in Prostate Cancer. Prostate Cancer SPORE workshop, Mayo Clinic, Rochester MN, February 1994.
4. Brown JA*, Alcaraz A, Takahashi S, Persons DL, Qian J, Herath JF, Bostwick DG, Lieber MM, Jenkins RB: Fluorescent in situ hybridization (FISH) analysis of prostate carcinoma: high frequency of chromosomal anomalies, correlation of aneusomy 7 with poor prognosis, and potential as a preoperative tool. American College of Physicians/Society of Air Force Physicians Annual Meeting, San Antonio TX, March 1994.
5. Alcaraz A*, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Katzmann JA, Lieber MM, Jenkins RB: Aneuploidy and aneusomy 7 detected by fluorescent in situ hybridization are potential cytogenetic markers of bad prognosis in prostate cancer. AACR, April 1994.
6. Brown JA*, Alcaraz A, Takahashi S, Persons Dl, Lieber MM, Jenkins RB: Chromosomal aneusomies detected by fluorescence in situ hybridization (FISH) analysis in clinically localized prostate carcinoma. Society for Basic Urologic Research meeting, San Francisco, CA, May 1994.
7. Takahashi S*, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB: Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Society for Basic Urologic Research meeting, San Franscico, CA, May 1994.
8. Alcaraz A*, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller J, Lieber MM, Jenkins RB: Aneuploidy and aneusomy 7 detected by fluorescent in situ hybridization (FISH) are associated with the poorest prognosis pathologic stage B & C prostate cancers. American Urological Association meeting, San Francisco, CA May 1994.
9. Brown JA*, Alcaraz A, Takahashi S, Bostwick DG, Persons DL, Qian J, Herath JF, Lieber MM, Jenkins RB: Fluorescence in situ hybridization (FISH) analysis of prostate cancer. Kimbrough Urological Seminar, Charleston SC, January 1995.
10. Brown JA*, Peterson DD, Lieber MM, Oesterling JE: Effects of terazosin and finasteride on prostate specific antigen (PSA) in men with benign prostatic hyperplasia (BPH). Kimbrough Urological Seminar, Charleston SC, January 1995.
11. Brown JA*, Peterson DD, Lieber MM, Oesterling JE: The effects of terazosin and finasteride on prostate specific antigen in men with benign hyperplasia. (American Urological Association, Las Vegas NV, April 1995.
9
12. Brown JA*, Takahashi S, Alcaraz A, Borell T, Qian J, Persons DL, Bostwick DG, Liber MM, Jenkins RB: Fluorescence in situ analysis of renal oncocytoma specimens reveals frequent loss of chromosomes Y and 1. American Urological Association meeting, Las Vegas NV, April 1995.
13. Brown JA*, Torres VE, King BF and Segura JW: Laparoscopic marsupialization of multiple renal cysts: a high rate of persistent and recurrent cysts and symptoms. American Urological Association meeting, Las Vegas NV, April 1995.
14. Takahashi S*, Alcaraz A, Brown JA, Borell TJ, Herath JF, Persons DL, Bergstralh EJ, Liber MM and Jenkins RB: Aneusomies detected by fluorescence in situ hybridization are prognostic markers for pathologic stage C (pT3) prostate cancer patients. American Urological Association meeting, Las Vegas NV, April 1995 – voted "best of session".
15. Brown JA*, Peterson DD, Lieber MM, and Oesterling JE: The effects of terazosin and finasteride on the serum PSA of men with benign prostatic hypertrophy. Kimbrough Urological Seminar, Washington DC, November 1995.
16. Brown JA*, Anderl K and Jenkins RB: Metaphase analysis of renal metanephric adenoma reveals loss of chromosome Y with gain of chromosomes 7 and 17. Kimbrough Urological Seminar, Washington DC, November 1995.
17. Brown JA*, Peterson DD, Lieber MM, and Oesterling JE: Terazosin and finasteride both lower the serum prostate specific antigen (PSA) level in men with benigh prostatic hyperplasia (BPH). American College of Physicians/Society of Air Force Physicians, San Antonio TX, March 1996.
18. Qian J*, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM and Jenkins RB. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histologic sections from paraffin-embedded prostatic adenocarcinoma specimens. United States and Canadian Academy of Pathology Meeting, March 1996.
19. Brown JA*, Elliott DS and Barrett DM: Post-prostatectomy urinary incontinence: a comparison of the cost of conservative versus surgical management. Urodynamics Society Annual Meeting, Orlando FL, May 1996.
20. Elliott DS*, Brown JA, Blute ML, Patterson DE and Barrett DM: A review of 308 consecutive AMS 800 urinary sphincter placements at the Mayo Clinic from January 1988 to February 1995: determination of the reoperation rate and the etiologies of re-operations. Urodynamics Society Annual Meeting, Orlando FL, May 1996.
21. Brown JA*, Peterson DD, Lieber MM, and Oesterling JE: Terazosin may lower the serum prostate specific antigen (PSA) concentration in men with benign prostatic hyperplasia (BPH). American Urological Association meeting, Orlando FL, May 1996.
10
22. Brown JA*, Elliott DS and Barrett DM: Post-prostatectomy urinary incontinence: a comparison of the cost of the conservative versus surgical management. American Urological Association meeting, Orlando FL, May 1996.
23. Petrou SP, Brown JA*, and Blaivas JG: Suprameatal transvaginal urethrolysis (STU): a simple, efficacious technique for treating bladder outlet obstruction after anti-incontinence procedures. American Urological Association meeting, Orlando FL, May 1996.
24. Brown JA*, Anderl KL, Borell TJ and Jenkins RB: Fluorescence in situ hybridization (FISH) and metaphase analysis of renal metanephric adenoma demonstrate chromosome Y loss and chromosome 7 and 17 gain. American Urological Association meeting, Orlando FL, May 1996.
25. Brown JA* and Petrou SP: Use of Ray-Tec sponge facilitates rib resection in flank incisions. American Urological Association meeting, Orlando FL, May 1996.
26. Brown JA*, Anderl KL, Borell TJ, Qian J, Bostwick DG and Jenkins RB: Fluorescence in situ hybridization (FISH) analysis of renal metanephric adenoma demonstrates chromosomes Y loss with chromosome 7 and 17 gain. North Central AUA meeting, Tucson AZ, October 1996.
27. Brown JA*, Takahashi S, Alcaraz A, Lieber MM and Jenkins RB: Fluorescence in situ hybridization (FISH) analysis is able to prospectively predict clinical or serum PSA progression in patients 3 years status post radical prostatectomy. Kimbrough Urological Seminar, Scottsdale, AZ, December 1996.
28. Qian J*, Bostwick DG, MacLennan GT, Brown JA, Farrow GM and Jenkins RB: Detection of genetic changes in collecting duct carcinoma of the kidney by fluorescence in situ hybridization (FISH). United States and Canadian Academy of Pathology meeting, March 1997.
29. Brown JA*, Takahashi S, Alcaraz A, Lieber MM and Jenkins RB. Prospective fluorescence in situ hybridization (FISH) analysis of prostate cancer is associated with clinical or serum prostate-specific antigen (PSA) progression in patients three years status post radical prostatectomy. American Urological Association, New Orleans, May 1997.
30. Brown JA*, Peterson D, Wollan P, Lieber MM and Oesterlling JE. Significant decrease in prostate-specific antigen (PSA) is observed in split frozen serum samples stored for more than one year. American Urological Association, New Orleans LA, May 1997.
31. Brown JA*, Nehra A, Barrett DM, Bite U, Doller M, Mulhal JP, Joel A and Goldstein I. Surgical management of subcutaneous silicone induced penile fibrosis. American Urological Association, New Orleans LA, May 1997.
32. Elliott DS*, Brown JA and Barrett DM. Long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: A review of 323 cases placed at the Mayo Clinic. American Urological Association, New Orleans LA, May 1997.
11
33. Brown JA*, Anderl KL, Borell TJ, Qian J, Bostwick DG and Jenkins RB. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provides evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. Mayo Laboratory Medicine/Pathology and Cancer Center Research Symposium, Rochester MN, May 1997.
34. Brown JA*, Slezak JM, Takahashi S, Alcaraz A, Lieber MM and Jenkins RB. Fluorescence in situ hybridization (FISH) analysis is prospectively associated with clinical or serum prostate-specific antigen (PSA) progression in patients three years status post radical prostatectomy. Mayo Laboratory Medicine/Pathology and Cancer Center Research Symposium, Rochester MN, May 1997.
35. Brown JA*, Peterson D, Wollan P, Lieber MM and Oesterling JE. Significant decrease in prostate-specific antigen (PSA) is observed in split frozen serum samples stored for more than one year. Mayo Laboratory Medicine/Pathology and Cancer Center Research Symposium, Rochester MN, May 1997.
36. Brown JA*, Anderl KL, Borell TJ, Qian J, Bostwick DG, and Jenkins RB. Is renal metanephric adenoma related to papillary renal cell carcinoma?
45th Annual Symposium of the Society of Air Force Clinical Surgeons, San Antonio, TX, April 1998.
37. Brown JA*, Slezak JM, Takahashi S, Alcaraz A, Lieber MM, and Jenkins RB. Can prospective fluorescence in situ hybridization (FISH) analysis
predict prostate cancer progression? 45th Annual Symposium of the Society of Air Force Clinical Surgeons, San Antonio, TX, April 1998.
38. Brown JA*, Barraza MA, and Erhard M. A midpole calyceal diverticulum mimicking Fraley’s Syndrome effectively treated by
retrograde balloon dilation. 16th World Congress on Endourology and SWL, New York City, NY, September 1998.
39. Brown JA*, Rodriguez M. Use of dry ice to create sterile ice slush: An
effective and inexpensive technique. 46th Annual James C. Kimbrough Urological Seminar, Williamsburg, VA, October 1998.
40. Brown JA*. Use of surgical clip as a hitch for folding and ligating the
vas deferens during partial vasectomy. 46th Annual James C. Kimbrough Urological Seminar, Williamsburg, VA, October 1998.
41. Brown JA*. Preservation of the proximal urethra during radical retropubic prostatectomy facilitates bladder neck preservation and
mucosal eversion. 46th Annual James C. Kimbrough Urological Seminar, Williamsburg, VA, October 1998.
42. Brown JA*. Distal control of the deep dorsal vein complex during radical retropubic prostatectomy: An effective, two-suture technique.
46th Annual James C. Kimbrough Urological Seminar, Williamsburg, VA, October 1998.
12
43. Brown JA*. Placement of the iliac crest over the kidney rest: an
improved flank position? 46th Annual Symposium of the Society of Air Force Clinical Surgeons, San Antonio, TX, March 1999.
44. Brown JA*. Use of a Kitner dissector facilitates proximal urethral mucosal preservation and mucosal eversion during bladder neck
sparing radical retropubic prostatectomy. 75th Annual Western Section AUA, Monterey CA, September 1999.
45. Brown JA*. Atypical renal angiomyolipomas: can we identify them
preoperatively? 47th Annual James C. Kimbrough Urological Seminar, San Antonio, TX, 1999.
46. Brown JA*: Renal insufficiency secondary to splenic compression: a
unique finding? 47th Annual James C. Kimbrough Urological Seminar, San Antonio, TX, 1999.
47. Diamond SM*, Garlitz S, Brown, JA: Hand-assisted laparoscopic ureterolysis. Mid-Atlantic Section AUA Meeting, 2002.
48. Strup SE*, Hubosky SH, Perotti M, Garlitz, CJ, Brown J, Moy L, Diamond, SM, Gomella LG: Use of fibrin sealant in hand-assisted laparoscopic partial nephrectomy: Influence of tumor location on operative morbidity. World Congress on Endourology & SWL, Genoa, Italy, 2002.
49. Garlitz CJ*, Perotti M, Brown J, Oh J, McGinnis DE, Gomella LG, Strup SE: Assessment of body mass index and learning curve as risk factors in laparoscopic radical prostatectomy. World Congress on Endourology & SWL, Genoa, Italy, 2002.
50. Brown JA*, Hubosky SG, Gomella LG, Diamond SM and Strup SE. Hand assisted laparoscopic partial nephrectomy (HALPN) for peripheral
and central lesions. 50th Annual James C. Kimbrough Urological Seminar, Washington, DC, December 2002.
51. Brown JA*, Garlitz C, Gomella LG, Diamond SM, McGinnis DE, Strup SE. Pathologic comparison of laparoscopic versus open radical
retropubic prostatectomy. 50th James C. Kimbrough Urological Seminar, Washington, DC, December 2002.
52. Brown, JA*, Garlitz C, Diamond SM, Gomella LG and Strup SE. Laparoscopic radical prostatectomy after neo-adjuvant hormonal
therapy: A safe and effective procedure. 50th James C. Kimbrough Urological Seminar, Washington, DC, December 2002.
53. Brown JA*, Garlitz C, Gomella LG, Diamond SM, McGinnis DE and Strup SE: Perioperative Morbidity of laparoscopic prostatectomy
compared with open radical retropubic prostatectomy. 50th James C. Kimbrough Urological Seminar, Washington, DC, December 2002.
54. Brown JA*, Hubosky SG, Gomella LG, Diamond SM, Strup SE. Hand-assisted laparoscopic partial nephrectomy (HALPN) for peripheral
and central lesions. 3rd Annual NIH Society of Urologic Oncologic Meeting, Bethesda, MD, December 2002.
13
55. Brown JA*, Garlitz C, Gomella LG, Diamond SM, McGinnis DE, Strup SE. Perioperative morbidity of laparoscopic radical prostatectomy
compared with open radical retropubic prostatectomy. 3rd Annual NIH Society of Urologic Oncologic Meeting, Bethesda, MD, December 2002.
56. Brown JA*, Garlitz C, Diamond SM, Gomella LG and Strup SE. Laparoscopic radical prostatectomy after neo-adjuvant hormonal therapy: A safe and effective procedure. Southeastern Section American Urological Association, Savannah, GA, March 2003.
57. Brown JA*, Hubosky SG, Gomella LG, Diamond SM and Strup SE. Hand-assisted laparoscopic partial nephrectomy (HALPN) for peripheral and central lesions. Southeastern Section American Urological Association Meeting, Savannah, GA, March 2003
58. Brown JA*, Garlitz C and Diamond SM. Hand assisted laparoscopic bilateral ureterolysis as treatment for patients with retroperitoneal fibrosis. Southeastern Section American Urological Association Meeting, Savannah, GA, March 2003.
59. Strup SE*, Hubosky S, Brown J, Diamond S and Gomella L. Hand-assisted laparoscopic partial nephrectomy (HALPN) with selective use of hilar clamping: evolution in technique. American Urological Association meeting, Chicago, IL, April 2003.
60. Strup SE*, Brown JA, Hubosky S and Gomella L. Hand assisted laparoscopic partial nephrectomy (HALPN): Evolution in technique and results in 61 patients. Society of Urologic Oncology Meeting, Bethesda, MD, December 2003.
61. Brown JA*, Rodin DM, Lee B and Dahl DM. Transperitoneal versus preperitoneal laparoscopic radical prostatectomy (LRP): An assessment of 156 cases. Society of Urologic Oncology Meeting, Bethesda, MD, December 2003
62. Brown JA*, Chenven E, Gomella LG, Strup SE and Bagley D. Hand-assisted laparoscopic nephroureterectomy (HALNU) with en bloc bladder cuff excision: Efficacy and recurrence rate in 59 consecutive cases. Society of Urologic Oncology Meeting, Bethesda, MD, December 2003.
63. Strup SE*, Brown JA, Hubosky S, Gomella L. Hand-assisted laparoscopic partial nephrectomy (HALPN): Evolution in technique and results in 61 patients. Society of Urologic Oncology Meeting, Bethesda, MD, December 2003.
64. Brown JA*. Staged partial nephrectomy: an effective nephron sparing and renal margin preserving technique. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
65. Brown JA*. Incorporation of hand-assisted laparoscopy into an academic training program: An assessment of the utility of a 3-month mini-fellowship. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
66. Brown JA* and Sundaram C. Optical-access visual obturator trocar entry into the desufflated abdomen during laparoscopy: An
14
assessment after 96 cases. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
67. Brown JA*, Chenven E, Gomella LG, Strup SE and Bagley D. Hand-assisted laparoscopic nephroureterectomy (HALNU) with en block bladder cuff excision: Efficacy and recurrence rate in 59 consecutive cases. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
68. Brown JA*, Rodin DM, Lee B and Dahl DM. Laparoscopic radical prostatectomy (LRP) and body mass index (BMI): An assessment of 157 sequential cases. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
69. Brown JA*, Rodin DM, Lee B and Dahl DM. Transperitoneal versus preperitoneal laparoscopic radical prostatectomy (LRP): An assessment of 156 cases. 51st Annual James C. Kimbrough Urological Seminar, San Antonio, TX, January 2004.
70. Brown JA*, Lymberakis C, Bihrle R, Foster RS. Delayed orchiectomy at time of retroperineal lymph node dissection (RPLND): An assessment of postchemotherapy pathologic and radiologic findings. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
71. Brown JA*, Chenven E, Gomella LG, Strup SE, Bagley D. Hand-assisted laparoscopic nephroureterectomy (HALNU) with en bloc bladder cuff excision: Efficacy and recurrence rate in 59 consecutive cases. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
72. Brown JA* and Sundaram CP. Optical-access visual obturator trocar entry into the desufflated abdomen during laparoscopy: An assessment after 96 cases. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
73. Brown JA*, Rodin DM, Lee B, Dahl DM. Laparoscopic radical prostatectomy (LRP) and body mass idex (BMI): An assessment of 157 sequential cases. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
74. Brown JA*, Rodin DM, Lee B, Dahl DM. Transperitoneal versus preperitoneal laparoscopic radical prostatectomy (LRP): An assessment of 156 cases. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
75. Boyd B* and Brown JA. Incorporation of hand-assisted laparoscopy into an academic training program: An assessment of the utility of a 3-month mini-fellowship. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
76. Lee BC*, Rodin DM, Sacco DE, Brown JA, Dahl DM. Laparoscopic radical nephrectomy is a cost-saving procedure compared to open radical nephrectomy for solid renal masses. AUA Annual Meeting, San Francisco, CA, May 2004.
77. Brown JA*, Rodin DM, Lee BC, Dahl DM. Transperitonial versus preperitoneal laparoscopic radical prostatectomy (LRP): An
15
assessment of 156 cases. AUA Annual Meeting, San Francisco, CA, May 2004.
78. Brown JA*, Bihrle R, Foster RS. Delayed orchiectomy at the time of retroperitoneal lymph node dissection (RPLND) in patients with presumed extragonadal germ cell tumor (EGT), a negative post-chemotherapy testis ultrasound and a lateralizing retroperitoneal metatstatic pattern on CT scan consistent with a testicular primary: An assessment of pathologic findings. AUA Annual Meeting, San Francisco, CA, May 2004.
79. Brown JA*, Bernie JE, Sundaram CP. Optical-access visual obturator trocar entry into the desufflated abdomen during laparoscopy: An assessment after 96 cases. AUA Annual Meeting, San Francisco, CA, May 2004.
80. Gargollo PC*, Sacco DE, Brown JA, Dahl DM. Difficult problems encountered during laparoscopic radical retropubic prostatectomy. AUA Annual Meeting, San Francisco, CA, May 2004
81. Brown JA* and Dahl DA. Does preoperative endorectal MRI impact on the laparoscopic radical prostatectomy margin rate? 5th annual Society of Urologic Oncology meeting, Bethesda MD, December 2004
82. Sajadi K* and Brown JA. Impact of six-month fellowship on initiation of a laparoscopic radical prostatectomy program. 5th annual Society of Urologic Oncology meeting, Bethesda MD, December 2004
83. Siddiqi K* and Brown JA. Staged Partial Nephrectomy: an institutional review. Georgia Urological Association and Urology Resident Research Expo. Lake Oconee, GA, Feb 2005
84. Shah S* and Brown JA. Non-healing Scrotal Abscess. Georgia Urological Association and Urology Resident Research Expo. Lake Oconee, GA, Feb 2005
85. Sajadi K* and Brown JA. Impact of six-month fellowship on initiation of a laparoscopic radical prostatectomy program. Georgia Urological Association and Urology Resident Research Expo. Lake Oconee, GA, Feb 2005
86. Brown JA*. A multi-institution minimally-invasive urologic oncology fellowship: a critical assessment of the clinical training and academic benefits. 69th Annual SESAUA meeting, Charleston, SC, March 2005
87. Brown JA*, Harisinghani M and Dahl DM. Assessment of accuracy of endorectal MRI in predicting prostate cancer tumor stage and impact on surgical margins. 69th Annual SESAUA meeting, Charleston, SC, March 2005
Sessions Moderated:
Peer-Reviewed Publications:1. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM and Jenkins
RB:
16
Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol, 152:1157-1162, 1994.
2. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB:Potential markers of prostate cancer aggressiveness detected by
fluorescence in situhybridization in needle biopsies. Cancer Res, 54:3574-3579, 1994.
3. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralf EJ, Larson-Keller JJ, Lieber MM, Jenkins RB: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res (Advances in Brief), 54:3998-4002, 1994.
4. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH: Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chrom Cancer, 11:153-162, 1994.
5. Takahashi S, Alcaraz A, Brown JA, Borell TJ, Herath JF, Bergstralh EJ, Lieber MM, and Jenkins RB: Aneusomies of chromosome 8 and Y detected by fluorescence in situhybridization are prognostic markers for pathologic stage C (pT3N0M0) prostate carcinoma. Clinical Cancer Research, 2:137-145, 1996.
6. Brown JA, Torres VE, King BF and Segura JW: Laparoscopic marsupialization of symptomatic polycystic kidney disease. J Urol, 106:22-27, 1996.
7. Brown JA, Takahashi S, Alcaraz A, Borell TJ, Andrel KL, Qian J, Persons DL, Bostwick DG, Lieber MM and Jenkins RB: Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J Urol, 156:31-35, 1996.
8. Brown JA, Sebo TJ, and Segura JW: Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain. Urology, 48:473-475, 1996.
9. Brown JA and Segura JW: A symptomatic testicular cyst in a patient with von Hippel-Lindau disease. Urology, 48:495-496, 1996.
10. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Leiber MM and Jenkins RB: Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. American Journal of Pathology, 149 (4):1193-1199, 1996.
11. Brown JA, Levy JB and Kramer SA: Genitourinary neurofibromatosis mimicking posterior urethral valves. Urology 49:960-962, 1997.
12. Brown JA and Petrou SP: Use of a surgical sponge facilitates rib resection in flank incisions. Urology 49:946-947, 1997.
13. Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DG and Jenkins RB: Simultaneous chromosome 7 and 17 gain and sex chromosome loss
17
provides evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J Urol, 158:370-374, 1997
14. Brown JA and Wilson TM: Benign prostatic hyperplasia requiring transurethral resection of the prostate in a 60 year old male to female transexual. Br J Urol, 80:956-957, 1997
15. Brown JA and Swanson SK: Bilateral synchronous renal metastases in a patient 13 years status post resection of adenoid cystic carcinoma of the salivary gland. Urology, 51:322-323, 1998
16. Brown JA, Segura JW and Blute ML: A giant left renal cyst presenting as obesity: a unique presentation. Urologia Espagne, Archivos Espanoles De Urologia, 51:105-107, 1998
17. Brown JA, Elliott DS and Barrett DM: Post-prostatectomy urinary incontinence: a comparison of the cost of conservative vs. surgical management. Urology, 51:715-720, 1998
18. Brown JA and Nehra A: Recurrent erythropoietin induced veno-occlusive priapism in a 25 year old male with end-stage renal disease. Urology, 52:328-330, 1998.
19. Petrou SP, Brown JA and Blaivas JG: Suprameatal transvaginal urethrolysis. J Urol 161:1268-1271, 1999
20. Schmidt, Jumker K, Nakaigawa N, Kinjerski T, Weirich G, Lubensky I, Neumann HPH, Brauch H, Decker J, Miller M, Vocke C, Jenkins R, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM and Zbar B: Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18:2343-2350, 1999.
21. Brown JA, Slezak JM, Lieber MM and Jenkins RB: Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy. Mayo Clin Proc 74:1214-1220, 1999
22. Brown, JA: End-Stage Autosomal Dominant Polycystic Kidney Disease. NEJM 347, (19):1504, 2002. (Article reprinted in Medical Tribune 38.Jahrgang, No. 6, Feb 2003)
23. Brown JA: Lateral gluteal myonecrosis in a patient undergoing partial nephrectomy in the modified flank position. Urology 61(2): 462, 2003. (illustration published in Laparoscopic Renal Surgery and the Risk of Rhabdomyolysis: Diagnosis and Treatment. Clayman RC et.al.)
24. Brown JA, Garlitz C, Hubosky S, Gomella LG, Diamond SM, McGinnis DE, Strup SE: Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy. Urology 62(3): 481-486, Sept 2003.(Article selected for CME credit testing)
25. Brown JA, Dahl DM. Transperitoneal laparaoscopic radical prostatectomy in patients after laparoscopic prosthetic mesh inguinal herniorrhaphy. Urology 63(2): 380-382, Feb 2004.
26. Brown JA, Garlitz C, Gomella LG, McGinnis DE, Diamond SM, Strup SE. Perioperative morbidity of laparoscopic radical prostatectomy compared with open radical retropubic prostatectomy. Urol Oncol 22(2): 102-106, March-April 2004.
18
27. Brown JA, Hubosky SC, Gomella LG, Strup SE. Hand-assisted laparoscopic partial nephrectomy for peripheral and central lesions: A review of 30 consecutive cases. J Urol 171(4): 1443-1446, April 2004.
28. Brown JA, Medlock MD, Dahl DM. Ventriculoperitoneal shunt externalization during laparoscopic prostatectomy. Urology 63(6): 1183-1185, June 2004.
29. Brown JA, Garlitz C, Gomella LG, Strup SE. Laparoscopic Radical Prostatectomy after Neoadjuvant Hormonal Therapy: An Apparently Safe and Effective Procedure. Journal of Laparoscopic & Advanced Surgical Techniques 14(6):335-338, December 2004.
30. Brown JA, Rodin DM, Lee B, Dahl DM. Laparoscopic Radical Prostatectomy (LRP) and Body Mass Index (BMI): An Assessment of 151 Sequential Cases. J Urol 173(2):442-445, February 2005. (reported on in Renal & Urology News article)
31. Brown JA, Rodin DM, Lee B, Dahl DM. Transperitoneal Versus Extraperitoneal Approach to Laparoscopic Radical Prostatectomy: An Assessment of 156 Cases. Urology 65(2):320-324, February 2005
32. Brown JA, Canal D, Sundaram CP. Optical-Access Obturator Trocar Entry Into the Desufflated Abdomen During Laparoscopy: An Assessment After 96 Cases. J Endourology 19(7):853-5, September 2005.
33. Brown JA, Strup SE, Chenven E, Bagley D, Gomella LG. Hand-assisted Laparoscopic Nephroureterectomy (HALNU): Analysis of Distal Ureterectomy Technique, Margin Status and Surgical Outcomes. Urology 66(6) -in press. (Article selected for CME credit testing)
Non-Peer-Reviewed Publications:1. Brown JA, Heit JA, Novicki DE: Urologic surgery and the anticoagulated
patient. American Urological Association Update Series, Lesson 19, volume XVII, 1998.
2. Brown JA and Gomella LG: Aggressive treatment for prostate cancer in the elderly: when is it appropriate? Geriatrics & Aging, 5(5):40-44, 2002.
3. Brown JA and Strup SE: Incorporating laparoscopic surgery into your urology practice. Contemporary Urology 15(2):12-21, 2003.
4. Brown JA: Prostate Cancer with James Brown, MD. Senior News, Augusta, October 2004.
5. Brown JA: Prostate Cancer with James Brown, MD. Senior News, Augusta 19(10):6, 2005.
Manuscripts Submitted:1. Brown JA, Chenven E, Strup SE, Bagley D, Gomella LG. Hand-assisted
laparoscopic nephroureterectomy (HALNU): an assessment of the impact of obesity in 50 procedures. (submitted Urology, 8/8/05)
19
2. Brown JA, Garlitz CJ, Hubosky SG, Gomella LG. Hand-Assisted Laparoscopic Ureterolysis to Treat Ureteral Obstruction Secondary to Idiopathic Retroperitoneal Fibrosis: Assessment of a Novel Technique and Initial Series. (re-submitted, Urology, 10/21/05)
Manuscripts In Preparation:1. Brown JA, Harisinghani M, Dahl DM. Impact of preoperative endorectal MRI on laparoscopic radical prostatectomy positive margin rate.2. Brown JA and Sundaram CP. Use of a Warming Bath to Prevent Lens
Fogging during Laparoscopy.3. Brown JA, Lymberlakis C, Bihrle R, Foster RS. Delayed orchiectomy at
post-chemotherapy retroperitoneal lymphadenectomy due to laterality of the retroperitoneal metastatic patter consistent with a testicular primary: an assessment of pathologic findings.
4. Brown JA, Lymberlakis C, Birhle R, Foster RS. Delayed orchiectomy at the time of postchemotherapy retroperitoneal lymphadenectomy: an assessment of postchemotherapy pathologic findings in the bleomycin-etoposide-cisplatin (BEP) era.
5. Sajadi K, Brown JA. Impact of six month laparoscopic prostatectomy fellowship on initiating a laparoscopic radical prostatectomy program.
6. Sajadi K, Brown JA. Impact of a 3 month hand-assisted laparoscopic nephrectomy fellowship followed by 3 month standard laparoscopic donor nephrectomy fellowship on initiating a laparoscopic donor nephrectomy program.
7. Siddiqi K, Brown JA. Impact of a 3 month hand-assisted laparoscopic renal surgery fellowship on initiation of a hand-assisted laparoscopic renal surgery teaching program.
8. Siddiqi K, Brown JA. Staged Partial Nephrectomy: an Institutional Review.9. Shah S, Brown JA. Perineal Sarcoma presenting as a non-healing ulcer.10. Shah S, Brown JA. The impact of pregnancy on an atypical
angiomyolipoma: an illustrative case report.11. Brown JA. A multi-institution minimally-invasive urologic oncology
fellowship: a critical assessment of the clinical training and academic benefits.
Books/Chapters:1. Brown JA and Jenkins RB: Fluorescence in-situ hybridization analysis
of prostate cancer. In An Introduction to Fluorescent In Situ Hybridization and Principles and Clinical Applications. Edited by M. Andreef and Daniel Pinkel, New York, John Wiley & Sons, 1999.
2. Brown JA and Gomella LG: Laparoscopic Hand-Assisted Nephrectomy and Nephroureterectomy. In Glenn’s Urologic Surgery. Sixth Edition.
20
Edited by Sam D. Graham, Jr., Lipincott Williams & Wilkins, Philadelphia PA, 2004
3. Brown J, Hemal A, Menon M. Vattakuti Institute Prostatectomy. In Prostate Cancer: Principles and Practice. Edited by Roger Kirby, Alan Partin, Mark Fenely and J. Kellogg Parsons, Martin Dunitz Ltd. (Taylor & Francis group), London (in press)
Internet Publications:
Videotapes:1. Gargollo PC*, Sacco DE, Brown JA, Dahl DM. Difficult problems
encountered during laparoscopic radical retropubic prostatectomy. AUA Annual Meeting, San Francisco, CA, May 2004
21